Ovation Science Inc. (OVATF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ovation Science Inc. (OVATF) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 61/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Ovation Science Inc. (OVATF) Resumen de Asistencia Médica y Tuberías
Ovation Science Inc. focuses on developing and marketing cannabis and hemp-based topical products using its patented Invisicare drug delivery technology. With operations in Canada, the United States, and Mexico, the company targets the health and wellness market through its Ovation and BASKiN brands, differentiating itself through innovative delivery systems.
Tesis de Inversión
Ovation Science Inc. presents a focused investment opportunity within the cannabis and hemp-based topical product market. The company's patented Invisicare technology provides a competitive edge in delivering cannabinoid-infused solutions. Key value drivers include expanding market penetration in Canada, the United States, and Mexico, along with the potential for new product development and licensing agreements. A gross margin of 81.5% indicates strong pricing power. However, the company's negative profit margin of -651.1% and limited market capitalization pose significant risks. Successful execution of its growth strategies and achieving profitability are critical for long-term value creation. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion into new geographic markets.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Patented Invisicare technology offers a unique drug delivery system for topical cannabis and hemp products.
- Gross margin of 81.5% demonstrates strong potential for profitability if sales volume increases.
- Operations in Canada, the United States, and Mexico provide access to key cannabis markets.
- Diverse product portfolio includes health and wellness, skincare, and sanitization products.
- Market Cap of $0.00B indicates the company is a microcap stock with high growth potential but also high risk.
Competidores y Pares
Fortalezas
- Patented Invisicare drug delivery technology
- Established brands in key markets
- Diverse product portfolio
- Experienced management team
Debilidades
- Negative profit margin
- Limited market capitalization
- Dependence on regulatory approvals
- Intense competition
Catalizadores
- Upcoming: Potential regulatory changes in the cannabis industry could expand market access.
- Ongoing: Expansion into new geographic markets will drive revenue growth.
- Ongoing: Strategic partnerships and licensing agreements can increase market reach.
- Upcoming: New product development and launches will enhance product portfolio.
- Ongoing: Increased brand awareness and marketing efforts will drive sales.
Riesgos
- Potential: Changing regulatory landscape could negatively impact operations.
- Ongoing: Increased competition in the cannabis market could erode market share.
- Potential: Product liability risks associated with cannabis products.
- Potential: Economic downturn could reduce consumer spending on discretionary items.
- Ongoing: Dependence on regulatory approvals for new products and markets.
Oportunidades de crecimiento
- Expansion into New Therapeutic Areas: Ovation Science can leverage its Invisicare technology to develop topical products targeting specific therapeutic areas such as pain management, dermatology, and wound healing. The global market for topical pain relief products is projected to reach $15.7 billion by 2027, presenting a significant opportunity for Ovation Science to expand its product offerings and capture market share. Timeline: 2-3 years.
- Geographic Expansion: The company can further expand its presence in existing markets and enter new geographic regions where cannabis and hemp products are legal. The European cannabis market is projected to reach €3.2 billion by 2025, offering a substantial growth opportunity for Ovation Science to establish a foothold in this emerging market. Timeline: Ongoing.
- Strategic Partnerships and Licensing Agreements: Ovation Science can pursue strategic partnerships with established pharmaceutical companies, retailers, and distributors to expand its market reach and access new customer segments. Licensing its Invisicare technology to other companies can also generate revenue and increase brand awareness. Timeline: Ongoing.
- New Product Development: The company can invest in research and development to create new and innovative cannabis and hemp-based products that address unmet needs in the market. This includes exploring new delivery methods, formulations, and ingredients to enhance product efficacy and appeal. Timeline: 1-2 years.
- Increased Brand Awareness and Marketing Efforts: Ovation Science can invest in marketing and advertising campaigns to increase brand awareness and drive sales of its products. This includes leveraging social media, influencer marketing, and public relations to reach target audiences and promote the benefits of its products. Timeline: Ongoing.
Oportunidades
- Expansion into new therapeutic areas
- Geographic expansion into new markets
- Strategic partnerships and licensing agreements
- New product development
Amenazas
- Changing regulatory landscape
- Increased competition
- Product liability risks
- Economic downturn
Ventajas competitivas
- Patented Invisicare drug delivery technology provides a competitive advantage.
- Established brands and distribution channels in key markets.
- Focus on innovation and product development.
- Expertise in cannabis and hemp product formulation and manufacturing.
Acerca de OVATF
Ovation Science Inc., established in 2017 and headquartered in Vancouver, Canada, specializes in the creation and distribution of cannabis and hemp-based products. The company's core technology, Invisicare, is a patented drug delivery system designed for topical and transdermal applications. This technology is central to the development of skincare and wellness products infused with hemp seed oil and cannabis. Ovation Science markets its products under several brands, including Ovation and BASKiN, which offer a range of topical solutions. Additionally, the company provides cannabidiol-infused health and wellness products under the Invibe MD brand, skincare solutions under the ARLO CBD name, and hand sanitizers under the DermSafe brand. Ovation Science operates in Canada, the United States, and Mexico, holding sublicenses for cannabis-based products and the Lighthouse brand for licensed dispensaries in the United States. The company aims to leverage its innovative technology and diverse product portfolio to capture a significant share of the growing cannabis and hemp market.
Qué hacen
- Develops and commercializes topical cannabis and hemp products.
- Utilizes patented Invisicare drug delivery technology.
- Offers cannabidiol-infused health and wellness solutions.
- Provides skincare solutions under the ARLO CBD brand.
- Markets hand sanitizers under the DermSafe name.
- Holds sublicenses for cannabis-based products.
- Operates in Canada, the United States, and Mexico.
Modelo de Negocio
- Develops and manufactures cannabis and hemp-based topical products.
- Markets and sells products through its own brands and distribution channels.
- Generates revenue through product sales and licensing agreements.
- Focuses on innovation and product development to maintain a competitive edge.
Contexto de la Industria
Ovation Science Inc. operates within the rapidly expanding cannabis and hemp industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis-based products for medicinal and recreational use. The market is characterized by intense competition, with numerous companies vying for market share in various segments, including topicals, edibles, and beverages. Ovation Science's focus on topical applications and its patented Invisicare technology position it to capitalize on the growing demand for innovative and effective cannabis-infused products. The company faces competition from both established pharmaceutical companies and emerging cannabis startups.
Clientes Clave
- Consumers seeking topical cannabis and hemp products for health and wellness.
- Patients seeking relief from pain, inflammation, and other conditions.
- Retailers and dispensaries that sell cannabis and hemp products.
- Companies that license Ovation Science's Invisicare technology.
Finanzas
Gráfico e información
Precio de la acción de Ovation Science Inc. (OVATF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para OVATF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para OVATF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para OVATF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de OVATF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Terry H. Howlett
CEO
Terry H. Howlett serves as the CEO of Ovation Science Inc. His background includes extensive experience in the pharmaceutical and healthcare industries. Prior to joining Ovation Science, he held leadership positions at various companies, focusing on product development, marketing, and sales. His expertise spans across multiple therapeutic areas, including dermatology and pain management. Howlett's experience in bringing innovative products to market is expected to drive Ovation Science's growth strategy.
Historial: Under Terry Howlett's leadership, Ovation Science has focused on expanding its product portfolio and market reach. Key milestones include the development and launch of new cannabis and hemp-based topical products, as well as the establishment of strategic partnerships to expand distribution channels. Howlett's strategic decisions have been instrumental in positioning Ovation Science as a leader in the cannabis topical market.
Información del mercado OTC de OVATF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ovation Science Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases investment risk.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- Fewer regulatory requirements compared to major exchanges.
- Potential for fraud or manipulation.
- Higher risk of delisting or going out of business.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Patented Invisicare technology.
- Operations in Canada, the United States, and Mexico.
- Experienced management team.
- Presence of established brands.
Preguntas Comunes Sobre OVATF
¿Cuáles son los factores clave para evaluar OVATF?
Ovation Science Inc. (OVATF) actualmente tiene una puntuación IA de 61/100, indicando puntuación moderada. Fortaleza clave: Patented Invisicare drug delivery technology. Riesgo principal a monitorear: Potential: Changing regulatory landscape could negatively impact operations.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de OVATF?
OVATF actualmente puntúa 61/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de OVATF?
Los precios de OVATF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre OVATF?
La cobertura de analistas para OVATF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en OVATF?
Las categorías de riesgo para OVATF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changing regulatory landscape could negatively impact operations.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de OVATF?
La relación P/E para OVATF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está OVATF sobrevalorada o infravalorada?
Determinar si Ovation Science Inc. (OVATF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de OVATF?
Ovation Science Inc. (OVATF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited due to OTC status.
- AI analysis is pending.